• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧 Wilms 肿瘤易感患者的遗传和表观遗传特征:来自儿童肿瘤协作组 AREN18B5-Q 的研究。

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.

机构信息

Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Division of Pediatric Surgery, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, 38105, USA.

出版信息

Nat Commun. 2023 Dec 18;14(1):8006. doi: 10.1038/s41467-023-43730-0.

DOI:10.1038/s41467-023-43730-0
PMID:38110397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10728430/
Abstract

Developing synchronous bilateral Wilms tumor suggests an underlying (epi)genetic predisposition. Here, we evaluate this predisposition in 68 patients using whole exome or genome sequencing (n = 85 tumors from 61 patients with matched germline blood DNA), RNA-seq (n = 99 tumors), and DNA methylation analysis (n = 61 peripheral blood, n = 29 non-diseased kidney, n = 99 tumors). We determine the predominant events for bilateral Wilms tumor predisposition: 1)pre-zygotic germline genetic variants readily detectable in blood DNA [WT1 (14.8%), NYNRIN (6.6%), TRIM28 (5%), and BRCA-related genes (5%)] or 2)post-zygotic epigenetic hypermethylation at 11p15.5 H19/ICR1 that may require analysis of multiple tissue types for diagnosis. Of 99 total tumor specimens, 16 (16.1%) have 11p15.5 normal retention of imprinting, 25 (25.2%) have 11p15.5 copy neutral loss of heterozygosity, and 58 (58.6%) have 11p15.5 H19/ICR1 epigenetic hypermethylation (loss of imprinting). Here, we ascertain the epigenetic and genetic modes of bilateral Wilms tumor predisposition.

摘要

双侧 Wilms 肿瘤的发生提示存在潜在的(表观)遗传易感性。在这里,我们使用外显子组或全基因组测序(n=61 例患者的 85 个肿瘤与其匹配的种系血液 DNA)、RNA-seq(n=99 个肿瘤)和 DNA 甲基化分析(n=61 个外周血、n=29 个非病变肾脏、n=99 个肿瘤)评估了 68 例患者的这种易感性。我们确定了双侧 Wilms 肿瘤易感性的主要事件:1)种系血液 DNA 中易于检测到的合子前遗传变异[WT1(14.8%)、NYNRIN(6.6%)、TRIM28(5%)和 BRCA 相关基因(5%)]或 2)11p15.5 上的 H19/ICR1 后合子表观遗传超甲基化,这可能需要分析多种组织类型进行诊断。在 99 个总肿瘤标本中,有 16 个(16.1%)保留了 11p15.5 的印迹正常,有 25 个(25.2%)存在 11p15.5 的拷贝中性杂合性丢失,有 58 个(58.6%)存在 11p15.5 的 H19/ICR1 表观遗传超甲基化(印迹丢失)。在这里,我们确定了双侧 Wilms 肿瘤易感性的表观遗传和遗传模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/93d33a0b230d/41467_2023_43730_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/1df7bcfd8cc8/41467_2023_43730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/629994dea5da/41467_2023_43730_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/10e481b51ccb/41467_2023_43730_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/f229d17094ef/41467_2023_43730_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/62f83b58e456/41467_2023_43730_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/93d33a0b230d/41467_2023_43730_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/1df7bcfd8cc8/41467_2023_43730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/629994dea5da/41467_2023_43730_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/10e481b51ccb/41467_2023_43730_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/f229d17094ef/41467_2023_43730_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/62f83b58e456/41467_2023_43730_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a35/10728430/93d33a0b230d/41467_2023_43730_Fig6_HTML.jpg

相似文献

1
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.双侧 Wilms 肿瘤易感患者的遗传和表观遗传特征:来自儿童肿瘤协作组 AREN18B5-Q 的研究。
Nat Commun. 2023 Dec 18;14(1):8006. doi: 10.1038/s41467-023-43730-0.
2
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study.双侧肾母细胞瘤易感性的遗传和表观遗传特征:儿童肿瘤研究组AREN18B5-Q研究报告
Res Sq. 2023 Mar 16:rs.3.rs-2675436. doi: 10.21203/rs.3.rs-2675436/v1.
3
The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes.双侧和多灶性肾母细胞瘤的病理生理学:从易感性综合征研究中学到的知识。
Pediatr Blood Cancer. 2023 May;70 Suppl 2:e29984. doi: 10.1002/pbc.29984. Epub 2022 Sep 12.
4
11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.在患有肾母细胞瘤和肝母细胞瘤的儿童的外周血中检测到 11p15.5 印记突变。
Cancer. 2020 Jul 1;126(13):3114-3121. doi: 10.1002/cncr.32907. Epub 2020 Apr 22.
5
Stratification of Wilms tumor by genetic and epigenetic analysis.通过基因和表观遗传学分析对肾母细胞瘤进行分层。
Oncotarget. 2012 Mar;3(3):327-35. doi: 10.18632/oncotarget.468.
6
Imprinting, expression, and localisation of DLK1 in Wilms tumours.DLK1在肾母细胞瘤中的印记、表达及定位
J Clin Pathol. 2005 Feb;58(2):145-50. doi: 10.1136/jcp.2004.021717.
7
Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.基因组分析绘制了杂合性缺失图谱,并确定了肾母细胞瘤中表观遗传和遗传事件的时间及阶段依赖性。
Mol Cancer Res. 2005 Sep;3(9):493-502. doi: 10.1158/1541-7786.MCR-05-0082.
8
Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.11号染色体p15.5区域印记:人类组织和肾母细胞瘤中KIP2和H19的比较分析
Hum Mol Genet. 1996 Aug;5(8):1101-8. doi: 10.1093/hmg/5.8.1101.
9
Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan.台湾地区威尔姆斯瘤中 WT2 上 H19DMR 和 KvDMR 的甲基化状态。
Pathol Oncol Res. 2020 Oct;26(4):2153-2159. doi: 10.1007/s12253-020-00802-6. Epub 2020 Mar 10.
10
Wilms tumor genes.肾母细胞瘤基因
Biochim Biophys Acta. 1993 Dec 23;1155(3):295-306. doi: 10.1016/0304-419x(93)90011-z.

引用本文的文献

1
NK cell-related genes-driven novel molecular subtyping and prognostic signatures for Wilms tumor: uncovering the therapeutic potential of TGX-221 and biomarker role of HS2ST1.NK细胞相关基因驱动的肾母细胞瘤新型分子亚型及预后特征:揭示TGX-221的治疗潜力及HS2ST1的生物标志物作用
Front Oncol. 2025 Aug 28;15:1593011. doi: 10.3389/fonc.2025.1593011. eCollection 2025.
2
Epigenetic Regulation in Wilms Tumor.肾母细胞瘤中的表观遗传调控
Biomedicines. 2025 Jul 9;13(7):1678. doi: 10.3390/biomedicines13071678.
3
From preneoplastic lesion to heterogenous tumor: recent insights into hepatoblastoma biology and therapeutic opportunities.

本文引用的文献

1
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update).DAVID:一个用于基因列表功能富集分析和功能注释的网络服务器(2021 更新)。
Nucleic Acids Res. 2022 Jul 5;50(W1):W216-W221. doi: 10.1093/nar/gkac194.
2
Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.5 年未选择的全国肾母细胞瘤队列中(表观)遗传易患因素的流行情况:全面的临床和基因组特征。
J Clin Oncol. 2022 Jun 10;40(17):1892-1902. doi: 10.1200/JCO.21.02510. Epub 2022 Mar 1.
3
Wilms tumour.
从癌前病变到异质性肿瘤:肝母细胞瘤生物学及治疗机遇的最新见解
Mol Cancer. 2025 Jul 19;24(1):198. doi: 10.1186/s12943-025-02405-8.
4
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.更新后的组织学良好型肾母细胞瘤风险分层:儿童肿瘤学组未来临床试验的理论依据
Nat Rev Urol. 2025 Jun 20. doi: 10.1038/s41585-025-01055-1.
5
Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor.家族性和双侧肾母细胞瘤中遗传和表观遗传易感性的不同途径。
Genome Med. 2025 May 8;17(1):49. doi: 10.1186/s13073-025-01482-0.
6
Wilms' Tumor: A Review of Clinical Characteristics, Treatment Advances, and Research Opportunities.肾母细胞瘤:临床特征、治疗进展及研究机会综述
Medicina (Kaunas). 2025 Mar 12;61(3):491. doi: 10.3390/medicina61030491.
7
Bilateral Wilms Tumor - Case Report of a Patient with Family History.双侧肾母细胞瘤——一例有家族病史患者的病例报告
Appl Clin Genet. 2024 Dec 16;17:199-203. doi: 10.2147/TACG.S495498. eCollection 2024.
8
Predisposition Footprints in the Somatic Genome of Wilms Tumors.肾母细胞瘤体细胞基因组中的易感性印记
Cancer Discov. 2025 Feb 7;15(2):286-298. doi: 10.1158/2159-8290.CD-24-0878.
9
Re-envisioning genetic predisposition to childhood and adolescent cancers.重新审视儿童和青少年癌症的遗传易感性。
Nat Rev Cancer. 2025 Feb;25(2):109-128. doi: 10.1038/s41568-024-00775-7. Epub 2024 Dec 3.
10
Pursuit of the optimal therapeutic approach and intensity for children with bilateral Wilms tumour.追求双侧肾母细胞瘤患儿的最佳治疗方法和强度。
Br J Cancer. 2024 Oct;131(6):970-971. doi: 10.1038/s41416-024-02806-4. Epub 2024 Aug 27.
威尔姆斯瘤。
Nat Rev Dis Primers. 2021 Oct 14;7(1):75. doi: 10.1038/s41572-021-00308-8.
4
Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group.高危儿童肾母细胞瘤监测:SIOP-Europe 宿主基因组工作组和 SIOP 肾肿瘤研究组的文献回顾和建议。
Eur J Cancer. 2021 Aug;153:51-63. doi: 10.1016/j.ejca.2021.05.014. Epub 2021 Jun 13.
5
Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime Cohort.与治疗暴露和儿童癌症长期幸存者心血管代谢结局风险相关的血液 DNA 甲基化的持续变化:圣裘德终身队列研究。
Genome Med. 2021 Apr 6;13(1):53. doi: 10.1186/s13073-021-00875-1.
6
TRIM28 variants and Wilms' tumour predisposition.TRIM28 变异与肾母细胞瘤易感性。
J Pathol. 2021 Jul;254(4):494-504. doi: 10.1002/path.5639. Epub 2021 Mar 15.
7
Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.WAGR 综合征伴 Wilms 瘤和/或肾母细胞瘤患儿的临床特征和结局:30 年来 SIOP-RTSG 的经验。
Cancer. 2021 Feb 15;127(4):628-638. doi: 10.1002/cncr.33304. Epub 2020 Nov 4.
8
Clinically and biologically relevant subgroups of Wilms tumour defined by genomic and epigenomic analyses.基于基因组和表观基因组分析定义的具有临床和生物学意义的肾母细胞瘤亚群。
Br J Cancer. 2021 Jan;124(2):437-446. doi: 10.1038/s41416-020-01102-1. Epub 2020 Oct 5.
9
Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X.个体癌症基因组中调控性非编码变异的发现,使用 cis-X 技术。
Nat Genet. 2020 Aug;52(8):811-818. doi: 10.1038/s41588-020-0659-5. Epub 2020 Jul 6.
10
Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.多中心或双侧易发性单侧肾母细胞瘤患者的治疗结果(AREN0534):来自儿童肿瘤学组的报告
Cancer. 2020 Aug 1;126(15):3516-3525. doi: 10.1002/cncr.32958. Epub 2020 May 27.